These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 7525495)
1. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Castellani P; Viale G; Dorcaratto A; Nicolo G; Kaczmarek J; Querze G; Zardi L Int J Cancer; 1994 Dec; 59(5):612-8. PubMed ID: 7525495 [TBL] [Abstract][Full Text] [Related]
2. The angiogenesis marker ED-B+ fibronectin isoform in intracranial meningiomas. Castellani P; Dorcaratto A; Pau A; Nicola M; Siri A; Gasparetto B; Zardi L; Viale G Acta Neurochir (Wien); 2000; 142(3):277-82. PubMed ID: 10819258 [TBL] [Abstract][Full Text] [Related]
3. Alternative splicing of the angiogenesis associated extra-domain B of fibronectin regulates the accessibility of the B-C loop of the type III repeat 8. Ventura E; Sassi F; Parodi A; Balza E; Borsi L; Castellani P; Carnemolla B; Zardi L PLoS One; 2010 Feb; 5(2):e9145. PubMed ID: 20161770 [TBL] [Abstract][Full Text] [Related]
4. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. Carnemolla B; Balza E; Siri A; Zardi L; Nicotra MR; Bigotti A; Natali PG J Cell Biol; 1989 Mar; 108(3):1139-48. PubMed ID: 2646306 [TBL] [Abstract][Full Text] [Related]
5. Oncofetal fibronectins in oral carcinomas: correlation of two different types. Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273 [TBL] [Abstract][Full Text] [Related]
6. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues. Kaczmarek J; Castellani P; Nicolo G; Spina B; Allemanni G; Zardi L Int J Cancer; 1994 Oct; 59(1):11-6. PubMed ID: 7927891 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissues. Borsi L; Balza E; Allemanni G; Zardi L Exp Cell Res; 1992 Mar; 199(1):98-105. PubMed ID: 1310473 [TBL] [Abstract][Full Text] [Related]
8. Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin. Castellani P; Borsi L; Carnemolla B; Birò A; Dorcaratto A; Viale GL; Neri D; Zardi L Am J Pathol; 2002 Nov; 161(5):1695-700. PubMed ID: 12414516 [TBL] [Abstract][Full Text] [Related]
9. C6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8. Ventura E; Cordazzo C; Quarto R; Zardi L; Rosano C PLoS One; 2016; 11(2):e0148103. PubMed ID: 26867013 [TBL] [Abstract][Full Text] [Related]
10. Distribution of fibronectin isoforms in human renal disease. Van Vliet A; Baelde HJ; Vleming LJ; de Heer E; Bruijn JA J Pathol; 2001 Feb; 193(2):256-62. PubMed ID: 11180174 [TBL] [Abstract][Full Text] [Related]
11. Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain. Carnemolla B; Neri D; Castellani P; Leprini A; Neri G; Pini A; Winter G; Zardi L Int J Cancer; 1996 Nov; 68(3):397-405. PubMed ID: 8903484 [TBL] [Abstract][Full Text] [Related]
13. Procedure for the purification of the fibronectin proteolytic fragments containing the ED-B oncofetal domain. Borsi L; Balza E; Leprini A; Ponassi M; Zardi L Anal Biochem; 1991 Feb; 192(2):372-9. PubMed ID: 2035837 [TBL] [Abstract][Full Text] [Related]
14. Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Kriegsmann J; Berndt A; Hansen T; Borsi L; Zardi L; Bräuer R; Petrow PK; Otto M; Kirkpatrick CJ; Gay S; Kosmehl H Rheumatol Int; 2004 Jan; 24(1):25-33. PubMed ID: 12712258 [TBL] [Abstract][Full Text] [Related]
15. Fibronectin isoforms are differentially expressed in normal and adenomatous human anterior pituitaries. Farnoud MR; Farhadian F; Samuel JL; Derome P; Peillon F; Li JY Int J Cancer; 1995 Mar; 61(1):27-34. PubMed ID: 7705930 [TBL] [Abstract][Full Text] [Related]
16. The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence. Carnemolla B; Leprini A; Allemanni G; Saginati M; Zardi L J Biol Chem; 1992 Dec; 267(34):24689-92. PubMed ID: 1280266 [TBL] [Abstract][Full Text] [Related]
17. A novel human fibronectin cryptic sequence unmasked by the insertion of the angiogenesis-associated extra type III domain B. Balza E; Sassi F; Ventura E; Parodi A; Fossati S; Blalock W; Carnemolla B; Castellani P; Zardi L; Borsi L Int J Cancer; 2009 Aug; 125(4):751-8. PubMed ID: 19479996 [TBL] [Abstract][Full Text] [Related]
18. Coordinate oncodevelopmental modulation of alternative splicing of fibronectin pre-messenger RNA at ED-A, ED-B, and CS1 regions in human liver tumors. Oyama F; Hirohashi S; Sakamoto M; Titani K; Sekiguchi K Cancer Res; 1993 May; 53(9):2005-11. PubMed ID: 8481903 [TBL] [Abstract][Full Text] [Related]
19. Distribution of ED-A and ED-B containing fibronectin isoforms in Dupuytren's disease. Halliday NL; Rayan GM; Zardi L; Tomasek JJ J Hand Surg Am; 1994 May; 19(3):428-34. PubMed ID: 8056970 [TBL] [Abstract][Full Text] [Related]